glp-1 receptor agonists mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Mechanism of action of GLP-1
Description
Albiglutide is generated from a genetic fusion of two modified recombinant GLP-1 (36) molecules linked in tandem to recombinant human albumin (90), while dulaglutide is created by conjugating two GLP-1 (37) analogues to the Fc fragment of a modified monoclonal antibody (IgG4) via peptide ((Gly 4 Ser) 3 Ala) linker (91)
J Am Soc Nephrol 2019;30:2229-42.ArticlePubMedPMC 43
Additionally, they inhibit the secretion of glucagon, a hormone that raises blood sugar levels, and slow gastric emptying, leading to a prolonged feeling of fullness and reduced appetite
doi: 10.1111/dom.14465 237 ElSayedNAAleppoGArodaVRBannuruRRBrownFMBruemmerDet al
The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE-/- mice by blocking monocyte/macrophage activation
This recommendation reflects a paradigm shift from a glucose-centric model toward a more comprehensive cardiometabolic approach
